Results 31 to 40 of about 32,295 (302)

Treatment-Resistant Schizophrenia

open access: yesFocus, 2020
Although, gratifyingly, research on the treatment of schizophrenia has increasingly focused on first-episode and prodromal patient populations, it is still recognized that many patients with more chronic illnesses exhibit a suboptimal response to treatments.
openaire   +3 more sources

Electroconvulsive Therapy for Treatment-Resistant Schizophrenia [PDF]

open access: yesSchizophrenia Bulletin, 2019
Electroconvulsive therapy (ECT) involves the induction of a seizure by the administration of an electrical stimulus via electrodes usually placed bilaterally on the scalp and was introduced as a treatment for schizophrenia in 1938. However, ECT is a controversial treatment with concerns about long-term side effects such a memory loss.
Diarmid J M, Sinclair   +5 more
openaire   +4 more sources

Metacognitive Therapy in Treatment-Resistant Psychosis:A Multiple-Baseline Study [PDF]

open access: yes, 2013
Background: More effective psychological treatments for psychosis are required. Case series data and pilot trials suggest metacognitive therapy (MCT) is a promising treatment for anxiety and depression.
Wardle, Melissa   +8 more
core   +1 more source

Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia [PDF]

open access: yesSchizophrenia Bulletin, 2017
Treatment-resistant schizophrenia (TRS) affects around one-third of individuals with schizophrenia. Although a number of sociodemographic and clinical predictors of TRS have been identified, data on the genetic risk of TRS are sparse. We aimed to investigate the association between a polygenic risk score for schizophrenia and treatment resistance in ...
Wimberley, Theresa   +5 more
openaire   +5 more sources

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia

open access: yesEuropean Psychiatry, 2021
Introduction Although clozapine is the gold standard for treating patients with resistant schizophrenia, clinical symptoms persist in approximately 40-70% of the cases even after a year of treatment with clozapine.
S. Khouadja   +3 more
doaj   +1 more source

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics [PDF]

open access: yes, 2013
There is a critical need for mapping early metabolic changes in schizophrenia to capture failures in regulation of biochemical pathways and networks.
Buckley, P   +45 more
core   +1 more source

A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia

open access: yes, 2023
BackgroundThis study aimed to conduct a systematic review and meta-analysis on cognitive performances of patients with treatment-resistant schizophrenia (TRS) after clozapine treatment and to examine the potential effect of follow-up duration and ...
Sherry Kit Wa Chan   +13 more
core   +1 more source

Clozapine combination and augmentation strategies in patients with schizophrenia: recommendations from an international expert survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group [PDF]

open access: yes, 2020
Evidence for the management of inadequate clinical response to clozapine in treatment-resistant schizophrenia is sparse. Accordingly, an international initiative was undertaken with the aim of developing consensus recommendations for treatment strategies
Schneider-Axmann, Thomas   +10 more
core   +1 more source

Cariprazine: Patients with Treatment-Resistant Schizophrenia

open access: yesNeuropsychiatric Disease and Treatment, 2021
Thomas Aubel Kliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Essen, GermanyCorrespondence: Thomas AubelKliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin ...
Aubel T
doaj  

Home - About - Disclaimer - Privacy